Home -> Law Blog Directory -> Legal News Blogs -> The Legal Intelligencer Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Legal News
: The Legal Intelligencer BlogMore Avandia Cases Settle
By Brian Harris
By Amaris Elliott-Engel
Of the Legal Staff
Last week, The Legal reported that the first bellwether trial in the Avandia Multidistrict Litigation, based in the U.S. District Court for the Eastern District of Pennsylvania, did not go off because two plaintiffs' attorneys settled their inventories.
Now, AmLaw Litigation Daily, an affiliate of The Legal, with a hat tip to Bloomberg for breaking the news, is reporting that the inventory settled 5,500 cases for $250 million, or an average of $46,000 each.
The settling attorneys were plaintiffs' attorneys Joseph J. Zonies, of Reilly Pozner in Denver, and Thomas Cartmell, of Wagstaff & Cartmell in Kansas City, Mo., settled their inventories.
The plaintiffs suing drugmaker GlaxoSmithKline over alleged injuries from their use of Avandia argue that it causes heart attacks, or myocardial infarctions, in diabetic patients taking the drug.
Full post as published by The Legal Intelligencer Blog on February 08, 2011 (boomark / email).
Unwed Fathers' Rights in Adoption
Landmark Cases in Adoption Law Shape Law with respect to Unwed Fathers
Avandia
alleging heart attacks, increased fracture risk that may have been caused by Avandia.
Salmonella Found in Tomotoes
57 Reported Cases in New Mexico and Texas
ConAgra Peanut Butter
Hundreds of Salmonella Cases Settled
Verizon To Pay $52 Million To Settle
Verizon To Pay $52 Million To Settle "Pay as You Go" Data Charges FCC Investigation
Disabilities Groups Settle with Caltrans for $1.1 Billion
Disabilities Groups Settle with Caltrans for $1.1 Billion
Bayer to Pay $3.3 Million To Settle One A Day Vitamin Claims
Bayer to Pay $3.3 Million To Settle One A Day Vitamin Claims

10,000 Avandia Lawsuits Settled For $460 Million While FDA Considers Possible Avandia Recall
Avandia Heart Attack: Questions Still Remain
Avandia Heart Attack Risk, Questions Remain
Physician Takes Issue With Fears Over Avandia Risk
Don't Cry for Avandia Maker Glaxo Just Yet
Avandia Decline Not Affecting GlaxoSmithKline








